Bethany Beazley

954 total citations
8 papers, 116 citations indexed

About

Bethany Beazley is a scholar working on Surgery, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Bethany Beazley has authored 8 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 2 papers in Dermatology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Bethany Beazley's work include Eosinophilic Esophagitis (6 papers), Dermatology and Skin Diseases (2 papers) and Autoimmune Bullous Skin Diseases (1 paper). Bethany Beazley is often cited by papers focused on Eosinophilic Esophagitis (6 papers), Dermatology and Skin Diseases (2 papers) and Autoimmune Bullous Skin Diseases (1 paper). Bethany Beazley collaborates with scholars based in United States, Netherlands and Australia. Bethany Beazley's co-authors include Lawrence Sher, Brad Shumel, Zhen Chen, Iftikhar Hussain, Diamant Thaçi, Andrew Blauvelt, Neil M.H. Graham, Lisa A. Beck, Marcella Ruddy and Faisal A. Khokhar and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and British Journal of Dermatology.

In The Last Decade

Bethany Beazley

8 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bethany Beazley United States 3 76 67 39 38 27 8 116
N I Ilina Russia 6 47 0.6× 84 1.3× 51 1.3× 19 0.5× 14 0.5× 51 123
Xian Sun United States 7 80 1.1× 68 1.0× 41 1.1× 72 1.9× 87 3.2× 14 188
Celeste M. Boesjes Netherlands 10 164 2.2× 118 1.8× 54 1.4× 32 0.8× 5 0.2× 17 185
Chitra R Natalie United States 4 140 1.8× 114 1.7× 49 1.3× 25 0.7× 4 0.1× 13 165
Anna Groblewska Poland 3 58 0.8× 120 1.8× 32 0.8× 12 0.3× 6 0.2× 8 174
Linde E. M. de Wijs Netherlands 7 204 2.7× 146 2.2× 87 2.2× 57 1.5× 3 0.1× 9 223
Agurtzane Bilbao Spain 5 12 0.2× 46 0.7× 16 0.4× 30 0.8× 22 0.8× 7 106
T. Bieber Germany 2 32 0.4× 90 1.3× 67 1.7× 7 0.2× 21 0.8× 3 109
José Antonio Ortega‐Martell Mexico 6 21 0.3× 30 0.4× 22 0.6× 10 0.3× 6 0.2× 19 64
Issac Goh United Kingdom 2 51 0.7× 15 0.2× 17 0.4× 6 0.2× 11 0.4× 2 82

Countries citing papers authored by Bethany Beazley

Since Specialization
Citations

This map shows the geographic impact of Bethany Beazley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bethany Beazley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bethany Beazley more than expected).

Fields of papers citing papers by Bethany Beazley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bethany Beazley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bethany Beazley. The network helps show where Bethany Beazley may publish in the future.

Co-authorship network of co-authors of Bethany Beazley

This figure shows the co-authorship network connecting the top 25 collaborators of Bethany Beazley. A scholar is included among the top collaborators of Bethany Beazley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bethany Beazley. Bethany Beazley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chehade, Mirna, Evan S. Dellon, Jonathan M. Spergel, et al.. (2023). 605 DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL. Gastroenterology. 164(6). S–112. 1 indexed citations
2.
Bredenoord, Albert J., Evan S. Dellon, Ikuo Hirano, et al.. (2023). 467 DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION. Gastroenterology. 164(6). S–90. 1 indexed citations
3.
Hirano, Ikuo, Margaret H. Collins, Evan S. Dellon, et al.. (2023). Sa1270 DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE PHASE 3 LIBERTY-EOE-TREET STUDY. Gastroenterology. 164(6). S–346. 1 indexed citations
4.
Spergel, Jonathan M., Lawrence Sher, Sandy Durrani, et al.. (2023). Dupilumab improves type 2 comorbidity outcomes in patients with eosinophilic esophagitis and comorbid disease at baseline: from Parts A and B of LIBERTY-EoE-TREET. Journal of Allergy and Clinical Immunology. 151(2). AB199–AB199. 2 indexed citations
5.
Murrell, Dédée F., P. Joly, Victoria P. Werth, et al.. (2023). 307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT. British Journal of Dermatology. 188(Supplement_2). 1 indexed citations
6.
Rothenberg, Marc E., Evan S. Dellon, Albert J. Bredenoord, et al.. (2022). Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study. Journal of Allergy and Clinical Immunology. 149(2). AB312–AB312. 7 indexed citations
7.
Dellon, Evan S., Marc E. Rothenberg, Ikuo Hirano, et al.. (2021). Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 Study. Journal of Allergy and Clinical Immunology. 147(2). AB91–AB91. 10 indexed citations
8.
Beck, Lisa A., Diamant Thaçi, Mette Deleuran, et al.. (2020). Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis. American Journal of Clinical Dermatology. 21(4). 567–577. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N I Ilina Breakdown of academic impact, for papers by Xian Sun Breakdown of academic impact, for papers by Celeste M. Boesjes Breakdown of academic impact, for papers by Chitra R Natalie Breakdown of academic impact, for papers by Anna Groblewska Breakdown of academic impact, for papers by Linde E. M. de Wijs Breakdown of academic impact, for papers by Agurtzane Bilbao Breakdown of academic impact, for papers by T. Bieber Breakdown of academic impact, for papers by José Antonio Ortega‐Martell Breakdown of academic impact, for papers by Issac Goh
Rankless by CCL
2026